Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study

This publication has 16 references indexed in Scilit:

• Influenza Vaccines
  Drugs, 1997
• French Economic Evaluations of Influenza and Influenza Vaccination
  PharmacoEconomics, 1996
• Amantadine and rimantadine resistance in influenza A viruses
  Current Opinion in Infectious Diseases, 1994
• 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
  Antimicrobial Agents and Chemotherapy, 1993
• Rational design of potent sialidase-based inhibitors of influenza virus replication
  Nature, 1993
• Selection and Characterization of a Neuraminidase-Minus Mutant of Influenza Virus and Its Rescue by Cloned Neuraminidase Genes
  Virology, 1993
• Amantadine for influenza A.
  BMJ, 1991
• Resistance of Influenza A Virus to Amantadine and Rimantadine: Results of One Decade of Surveillance
  The Journal of Infectious Diseases, 1989
• Economic impact of influenza: The individual's perspective
  The American Journal of Medicine, 1987
• Influenza: Quantifying morbidity and mortality
  The American Journal of Medicine, 1987